| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.86B | 23.10B | 26.13B | 23.62B | 22.37B | 20.87B |
| Gross Profit | 10.75B | 9.05B | 10.77B | 9.79B | 9.57B | 8.99B |
| EBITDA | 3.30B | 1.55B | 3.28B | 3.09B | 3.16B | 3.48B |
| Net Income | 1.66B | 286.76M | 1.69B | 1.69B | 1.92B | 2.11B |
Balance Sheet | ||||||
| Total Assets | 40.39B | 39.83B | 41.05B | 42.82B | 40.84B | 36.89B |
| Cash, Cash Equivalents and Short-Term Investments | 11.97B | 11.87B | 11.69B | 13.41B | 16.17B | 12.40B |
| Total Debt | 195.76M | 0.00 | 5.96M | 8.86M | 7.40M | 1.16M |
| Total Liabilities | 5.20B | 5.05B | 5.55B | 8.40B | 8.26B | 5.85B |
| Stockholders Equity | 34.85B | 34.37B | 35.11B | 34.07B | 32.28B | 30.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.03B | -985.94M | -225.33M | 4.30B | 1.24B |
| Operating Cash Flow | 0.00 | 1.35B | -377.69M | 119.09M | 4.61B | 2.08B |
| Investing Cash Flow | 0.00 | 189.60M | -129.64M | -2.52B | -299.61M | -1.34B |
| Financing Cash Flow | 0.00 | -1.74B | -720.50M | -1.07B | -695.63M | -763.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥99.14B | 136.93 | 5.02% | 3.23% | -30.60% | -84.58% | |
79 Outperform | ¥129.51B | 9.64 | ― | 3.24% | 8.95% | 18.54% | |
79 Outperform | ¥49.85B | 12.82 | ― | 3.47% | 8.25% | -7.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥24.10B | 126.75 | ― | 2.77% | -11.58% | -82.90% |